See the full story in the original article.
Original headline: Medicare Open Enrollment Begins , 2027 Plan Changes Announced
Read the original on 1059thex.iheart.com ↗
Related news
- Medicare Open Enrollment Begins, 2027 Plan Changes Announced
Medicare open enrollment runs from October 15 to December 7 for coverage effective January 1, 2027, affecting more than 70 million enrollees. Beneficiaries can choose traditional Medicare, private Medicare Advantage plans, or prescription drug plans. The Social Security Administration says benefits will rise 3.6% in 2027, about $75 more per month for nearly 72 million recipients. The Part D out-of-pocket cap rises from $2,100 in 2026 to $2,400 in 2027, the standard deductible increases from $615 to $700, and a temporary Part D premium subsidy will end early at year's end. Negotiated prices for 15 drugs take effect January 1, and CMS projects a $685 million impact on Medicare prescription drug coverage in 2027.
- Medicare Open Enrollment Begins , 2027 Plan Changes Announced
- Medicare Open Enrollment Begins , 2027 Plan Changes Announced
Medicare open enrollment runs from October 15 to December 7, letting beneficiaries choose coverage effective January 1, 2027, as more than 70 million enrollees face changes to prescription drug costs. Social Security benefits will rise 3.6% in 2027, about $75 more per month for nearly 72 million recipients. The Part D out-of-pocket cap will increase from $2,100 in 2026 to $2,400 in 2027, and the standard deductible from $615 to $700. A temporary Part D premium subsidy will end early, and Medicare-negotiated prices for 15 drugs, including Ozempic and Wegovy, take effect January 1; CMS expects the change to lower prescription drug coverage for enrollees by $685 million in 2027. Separately, President Donald Trump announced one-time payments of $90 in October for more than 20 million enrollees to help cover Part B premiums, costing about $2 billion and excluding roughly 35 million Medicare Advantage enrollees.
- Medicare Open Enrollment Begins, 2027 Plan Changes Announced
Medicare open enrollment starts Thursday (October 15) and runs until December 7, letting beneficiaries choose coverage effective January 1, 2027, as more than 70 million enrollees face changes to prescription drug coverage. The out-of-pocket cap for Part D drugs rises to $2,400 from $2,100, and the standard deductible increases from $615 to $700. A temporary Part D premium subsidy will end early as the Trump administration concludes the program at year's end, though CMS projects only modest price increases for most people. Negotiated prices for 15 drugs take effect January 1, and CMS estimates this will lower prescription drug coverage by $685 million in 2027.
- Medicare Open Enrollment Begins , 2027 Plan Changes Announced
Medicare open enrollment starts Thursday (October 15) and runs until December 7, with changes taking effect January 1, 2027 for more than 70 million enrollees. The Part D out-of-pocket cap rises to $2,400 from $2,100 and the standard deductible increases from $615 to $700, while a temporary Part D premium subsidy ends early at year's end. Social Security benefits will rise 3.6 percent in 2027, about $75 more per month for nearly 72 million recipients. Medicare-negotiated prices take effect for 15 drugs, including Ozempic and Wegovy, and CMS projects the change will reduce prescription drug coverage by $685 million in 2027. President Trump also announced one-time $90 payments in October for more than 20 million Medicare enrollees to help with Part B premiums, costing about $2 billion.
- Medicare Open Enrollment Begins, 2027 Plan Changes Announced
Medicare open enrollment runs from Thursday, October 15, to December 7, letting more than 70 million enrollees choose plans effective January 1, 2027. The Social Security Administration set a 3.6 percent cost-of-living increase for 2027, adding $75 a month for nearly 72 million beneficiaries. The Part D out-of-pocket cap will rise from $2,100 in 2026 to $2,400 in 2027, and the standard deductible from $615 to $700, while a temporary Part D premium subsidy started in 2024 will end early at year's end. CMS expects only modest premium increases for most people, and negotiated prices for 15 drugs, including Ozempic and Wegovy, take effect January 1, with CMS projecting a $685 million effect on drug costs in 2027. President Trump also announced one-time $90 payments in October to more than 20 million people paying Part B premiums, costing about $2 billion.
Related markets
Latest news
- Internet down: Google Cloud outage leaves websites including Lloyds Bank, Rightmove and DPD not working
A major internet outage appears to have taken down many websites and apps, including Lloyds Bank, HSBC, Screwfix, DPD and internet bank Revolut, according to Down Detector. At least some of the problems seem linked to Google Cloud, where Google confirmed issues with multiple services at its west Europe facilities and said there was no workaround. The article notes it is unclear whether all the disruptions are related. It also points out that cloud infrastructure providers such as Google Cloud, Cloudflare and Amazon Web Services are largely invisible yet support much of the internet, so an outage at one can knock out many seemingly unrelated services.
- BlackRock Files for 'Buffer' Bitcoin ETF as IBIT Draws $665M in a Day
BlackRock has filed with the SEC for the iShares Bitcoin Managed Protection ETF (ticker PBIT), a 'buffer' fund that would limit initial losses to about 10% in exchange for capping gains. Instead of holding Bitcoin directly, it would buy call options on IBIT or similar exposure, sell higher-priced calls to offset costs, use three overlapping monthly tranches, and hold fixed-income investments. The management fee has not been set. On the same day, IBIT was the only one of 12 U.S. spot Bitcoin ETFs to post net inflows, at $665.2 million, while the group's total net inflows were $526.6 million. The funds had shed about $910 million over the previous two weeks as hotter-than-expected inflation data revived bets on another Federal Reserve rate hike.
- The Best Trillion-Dollar Stock to Buy Right Now, According to Wall Street
According to the article, 13 U.S.-listed stocks have a market capitalization of at least $1 trillion, and analysts are most bullish on Micron, with a median target price of $1,575 per share, implying 70% upside from the current $925. Micron's results have surged amid a memory chip shortage driven by AI infrastructure demand: revenue in the September quarter rose 379% to $54 billion, and non-GAAP earnings reached $33.42 per diluted share, up from $3.03 a year earlier. The CEO expects tighter supply-demand conditions in fiscal 2027 and 2028. However, new capacity from Micron, Samsung, SK Hynix and others could lead to oversupply by 2029, and memory prices have historically fallen sharply in such periods. Some investors believe AI demand and longer contracts could weaken the boom-and-bust pattern, while others remain cautious.
- PNJ Shares 'Surge' Ahead of Extraordinary Shareholders' Meeting
PNJ shares hit the daily ceiling of 19,750 dong ahead of an extraordinary shareholders' meeting, with more than 4 million shares in unfilled buy orders at the ceiling price and matched volume above 16 million shares, worth over 315 billion dong. Foreign investors returned as net buyers of over 3.5 million shares after heavy selling. At the meeting, the company will present a restructuring plan following the diamond incident, including cutting this year's revenue target by about 20% to around 39,000 billion dong and setting aside over 7,071 billion dong in provisions, which would swing projected after-tax profit from 3,400 billion dong to a loss of 6,271 billion dong. It also proposes lowering last year's dividend payout from 20% to 10% and issuing up to 550 million shares privately. The stock has lost about 70% of its value since early July.
- Nvidia Stock Hasn’t Been This Cheap in 7 Years. Only 1 Explanation Makes Sense.
Nvidia's trailing P/E ratio is about 27, its lowest since June 2019 and less than half its 10-year average of 61.3, even though the share price has nearly tripled since Aswath Damodaran called the stock a bridge too far in early 2024. The article argues the only mathematical explanation is that earnings are growing faster than the share price, with second quarter fiscal 2027 revenue up 106% to $92.6 billion and earnings up 126%. Damodaran's 2024 valuation model assumed revenue growth of around 32% a year over five years, a pace Nvidia is now far exceeding. Risks noted include doubts about returns on huge AI infrastructure spending, local opposition to data centers, and rising competition from AMD and customers such as Amazon, Google and Microsoft. The author says Damodaran was badly wrong about Nvidia and suggests the trend could continue.
- Coteccons shifts growth focus as construction sector gains major rivals
Coteccons (CTD) views the entry of VinCons (Vingroup) and Tân Minh Nhân (Sun Group) as a force raising industry standards, and its chairman Bolat Duisenov prefers not to compare the company with other contractors. Instead, management focuses on three questions: how to become investors' first choice, how to attract and retain talent, and how to diversify revenue. In fiscal 2026, net revenue rose 38% to VND 34,340 billion and after-tax profit rose 73% to VND 788 billion, while backlog reached a record VND 70,000 billion. The company targets revenue of VND 42,000 billion and profit of VND 1,050 billion for fiscal 2027, although new contracts signed in Q1 of fiscal 2027 totaled VND 14,519 billion, down year on year, as it tightens client and project selection. Bolat said the company can sustain 20-30% growth in the coming years and is shifting its focus from volume to efficiency.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.